$143.2
+0.86
(+0.6%)▲
Insights on The Clorox Company
Revenue is up for the last 2 quarters, 1.38B → 1.99B (in $), with an average increase of 30.4% per quarter
Netprofit is up for the last 2 quarters, 22.0M → 93.0M (in $), with an average increase of 76.3% per quarter
In the last 1 year, Colgate-palmolive Co. has given 14.8% return, outperforming this stock by 26.1%
In the last 3 years, Procter & Gamble Company, The has given 7.5% return, outperforming this stock by 32.9%
0.61%
Downside
Day's Volatility :0.73%
Upside
0.12%
20.59%
Downside
52 Weeks Volatility :34.53%
Upside
17.55%
Period | The Clorox Company | Sector (Consumer Staples) | S&P500 |
---|---|---|---|
3 Months | -0.7% | 1.5% | 5.0% |
6 Months | 14.18% | 7.9% | 16.4% |
1 Year | -11.31% | -3.3% | 20.9% |
3 Years | -25.07% | 5.1% | 20.0% |
Market Capitalization | 17.7B |
Book Value | $0.43 |
Dividend Share | 4.78 |
Dividend Yield | 3.42% |
Earnings Per Share (EPS) | 0.64 |
PE Ratio | 222.63 |
PEG Ratio | 0.43 |
Wall Street Target Price | 152.82 |
Profit Margin | 1.09% |
Operating Margin TTM | 16.43% |
Return On Assets TTM | 8.91% |
Return On Equity TTM | 26.23% |
Revenue TTM | 7.3B |
Revenue Per Share TTM | 59.0 |
Quarterly Revenue Growth YOY | 16.0% |
Gross Profit TTM | 2.9B |
EBITDA | 1.1B |
Diluted Eps TTM | 0.64 |
Quarterly Earnings Growth YOY | -0.06 |
EPS Estimate Current Year | 5.59 |
EPS Estimate Next Year | 6.41 |
EPS Estimate Current Quarter | 1.1 |
EPS Estimate Next Quarter | 1.45 |
What analysts predicted
Upside of 6.72%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 6.1B | ↑ 2.53% |
Net Income | 823.0M | ↑ 17.4% |
Net Profit Margin | 13.44% | ↑ 1.7% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 6.2B | ↑ 1.47% |
Net Income | 820.0M | ↓ 0.36% |
Net Profit Margin | 13.2% | ↓ 0.24% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 6.7B | ↑ 8.16% |
Net Income | 939.0M | ↑ 14.51% |
Net Profit Margin | 13.97% | ↑ 0.77% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 7.3B | ↑ 9.22% |
Net Income | 710.0M | ↓ 24.39% |
Net Profit Margin | 9.67% | ↓ 4.3% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 7.1B | ↓ 3.19% |
Net Income | 462.0M | ↓ 34.93% |
Net Profit Margin | 6.5% | ↓ 3.17% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 7.4B | ↑ 3.97% |
Net Income | 149.0M | ↓ 67.75% |
Net Profit Margin | 2.02% | ↓ 4.48% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.7B | ↓ 3.39% |
Net Income | 85.0M | ↓ 15.84% |
Net Profit Margin | 4.89% | ↓ 0.72% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.7B | ↓ 1.44% |
Net Income | 99.0M | ↑ 16.47% |
Net Profit Margin | 5.77% | ↑ 0.88% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.9B | ↑ 11.66% |
Net Income | -209.0M | ↓ 311.11% |
Net Profit Margin | -10.91% | ↓ 16.68% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.0B | ↑ 5.43% |
Net Income | 176.0M | ↓ 184.21% |
Net Profit Margin | 8.72% | ↑ 19.63% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.4B | ↓ 31.35% |
Net Income | 22.0M | ↓ 87.5% |
Net Profit Margin | 1.59% | ↓ 7.13% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.0B | ↑ 43.58% |
Net Income | 93.0M | ↑ 322.73% |
Net Profit Margin | 4.67% | ↑ 3.08% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 5.1B | ↑ 10.65% |
Total Liabilities | 4.3B | ↑ 7.52% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 5.1B | ↑ 1.11% |
Total Liabilities | 4.6B | ↑ 5.15% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 6.2B | ↑ 21.44% |
Total Liabilities | 5.3B | ↑ 16.41% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 6.3B | ↑ 1.95% |
Total Liabilities | 5.7B | ↑ 8.24% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 6.2B | ↓ 2.78% |
Total Liabilities | 5.4B | ↓ 5.45% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 5.9B | ↓ 3.46% |
Total Liabilities | 5.6B | ↑ 2.36% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 6.2B | ↓ 0.08% |
Total Liabilities | 5.7B | ↑ 4.2% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 6.0B | ↓ 1.76% |
Total Liabilities | 5.6B | ↓ 1.82% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.8B | ↓ 3.76% |
Total Liabilities | 5.6B | ↑ 1.66% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.9B | ↑ 2.18% |
Total Liabilities | 5.6B | ↓ 1.58% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.0B | ↑ 0.77% |
Total Liabilities | 5.9B | ↑ 5.45% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.9B | ↓ 1.39% |
Total Liabilities | 5.7B | ↓ 2.9% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 974.0M | ↑ 12.21% |
Investing Cash Flow | -859.0M | ↑ 319.02% |
Financing Cash Flow | -399.0M | ↓ 38.14% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 992.0M | ↑ 1.85% |
Investing Cash Flow | -196.0M | ↓ 77.18% |
Financing Cash Flow | -815.0M | ↑ 104.26% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.5B | ↑ 55.85% |
Investing Cash Flow | -252.0M | ↑ 28.57% |
Financing Cash Flow | -523.0M | ↓ 35.83% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.3B | ↓ 17.46% |
Investing Cash Flow | -452.0M | ↑ 79.37% |
Financing Cash Flow | -1.4B | ↑ 165.97% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 786.0M | ↓ 38.4% |
Investing Cash Flow | -229.0M | ↓ 49.34% |
Financing Cash Flow | -689.0M | ↓ 50.47% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.2B | ↑ 47.33% |
Investing Cash Flow | -223.0M | ↓ 2.62% |
Financing Cash Flow | -753.0M | ↑ 9.29% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 178.0M | ↓ 46.87% |
Investing Cash Flow | -45.0M | ↓ 27.42% |
Financing Cash Flow | -35.0M | ↓ 89.26% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 209.0M | ↑ 17.42% |
Investing Cash Flow | -42.0M | ↓ 6.67% |
Financing Cash Flow | -280.0M | ↑ 700.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 341.0M | ↑ 63.16% |
Investing Cash Flow | -55.0M | ↑ 30.95% |
Financing Cash Flow | -211.0M | ↓ 24.64% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 430.0M | ↑ 26.1% |
Investing Cash Flow | -81.0M | ↑ 47.27% |
Financing Cash Flow | -227.0M | ↑ 7.58% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 20.0M | ↓ 95.35% |
Investing Cash Flow | -23.0M | ↓ 71.6% |
Financing Cash Flow | 155.0M | ↓ 168.28% |
Sell
Neutral
Buy
The Clorox Company is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
The Clorox Company | -4.37% | 14.18% | -11.31% | -25.07% | -7.26% |
Colgate-palmolive Co. | -1.72% | 18.72% | 14.84% | 7.94% | 25.09% |
Estée Lauder Companies Inc. | -6.62% | -0.43% | -46.3% | -55.35% | -18.96% |
Procter & Gamble Company, The | -2.64% | 4.62% | 3.8% | 14.9% | 48.01% |
Kenvue Inc. | -4.6% | -3.94% | -28.36% | -28.36% | -28.36% |
Kimberly-clark Corp. | 1.39% | 2.05% | -9.2% | -9.34% | 1.95% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
The Clorox Company | 222.63 | 222.63 | 0.43 | 5.59 | 0.26 | 0.09 | 0.03 | 0.43 |
Colgate-palmolive Co. | 31.11 | 31.11 | 2.15 | 3.49 | 2.79 | 0.15 | 0.02 | 0.74 |
Estée Lauder Companies Inc. | 106.15 | 106.15 | 1.6 | 2.25 | 0.07 | 0.03 | 0.02 | 15.94 |
Procter & Gamble Company, The | 26.12 | 26.12 | 3.28 | 6.45 | 0.32 | 0.11 | 0.03 | 20.28 |
Kenvue Inc. | 21.34 | 21.34 | 2.11 | 1.14 | 0.11 | 0.07 | 0.04 | 5.85 |
Kimberly-clark Corp. | 24.05 | 24.05 | 1.57 | 6.9 | 2.0 | 0.1 | 0.04 | 2.72 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
The Clorox Company | Sell | $17.7B | -7.26% | 222.63 | 1.09% |
Colgate-palmolive Co. | Buy | $70.8B | 25.09% | 31.11 | 11.82% |
Estée Lauder Companies Inc. | Buy | $49.2B | -18.96% | 106.15 | 3.08% |
Procter & Gamble Company, The | Buy | $367.0B | 48.01% | 26.12 | 17.6% |
Kenvue Inc. | Buy | $36.8B | -28.36% | 21.34 | 10.77% |
Kimberly-clark Corp. | Hold | $42.2B | 1.95% | 24.05 | 8.63% |
Vanguard Group Inc
BlackRock Inc
State Street Corporation
FMR Inc
Geode Capital Management, LLC
Morgan Stanley - Brokerage Accounts
In the quarter ending March,2024. The Clorox Company has declared dividend of $1.2
Read Moreclorox is a global company with leading brands that have become household names: our namesake bleach and cleaning products; ayudín® and poett® home care products; pine-sol® dilutable cleaner; fresh step® cat litter; kingsford® charcoal; hidden valley® and k c masterpiece® dressings and sauces; brita® water filtration products; glad® bags, wraps and containers; and burt's bees® natural personal care products. we manufacture products in more than two dozen countries and market them in more than 100 countries. clorox trades on the new york stock exchange under the symbol clx.
Organization | The Clorox Company |
Employees | 8700 |
CEO | Ms. Linda Rendle |
Industry | Consumer Non-Durables |